Jing Li

14PUBLICATIONS
74CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Genome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)Powder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 24, 2026
The Oncogenic EGFR-SHC1 Fusion Confers Insensitivity to EGFR-TKIs via Dual Activation of N-EGFR Kinase Domain and C-SHC1 Phosphorylation Sites in Lung Cancer.

Jiani Zheng, Shen Zhao, Jianhua Zhan

|Nov 01, 2025
A special latch in yeast mitofusin guarantees mitochondrial fusion by stabilizing self-assembly.

Shu-Jing Huang, Dong-Fei Ma, Caiting Yu

|Apr 15, 2025
CCN1 is a therapeutic target upregulated in EML4-ALK mutant lung adenocarcinoma reversibly resistant to alectinib.

Yihua Huang, Jie Huang, Jianhua Zhan

|Oct 29, 2024
ScRAPdb: an integrated pan-omics database for the Saccharomyces cerevisiae reference assembly panel.

Zepu Miao, Yifan Ren, Andrea Tarabini

|Apr 10, 2024
Chidamide plus envafolimab as subsequent treatment in advanced non-small cell lung cancer patients resistant to anti-PD-1 therapy: A multicohort, open-label, phase II trial with biomarker analysis.

Yaxiong Zhang, Zihong Chen, Yu Liu

|Apr 05, 2024
Co-occurring EGFR p.E709X Mutation Mediates Primary Resistance to the Third-Generation EGFR-TKIs in EGFR p.G719X-Mutant Patients with Advanced NSCLC.

Lanlan Pang, Yihua Huang, Weitao Zhuang

Pageof 3

Frequent Collaborators

7 joint publications

Jia-Xing Yue

5 joint publications

Gianni Liti

2 joint publications

Feng Hao

2 joint publications

Huihui Li